Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
EGFR Antibody (SPM622), PE/Atto594, Novus Biologicals™

Mouse Monoclonal Antibody
Supplier: Novus Biologicals NBP247741PEATT594
Description
EGFR Monoclonal specifically detects EGFR in Human samples. It is validated for Flow Cytometry.Specifications
| EGFR | |
| Monoclonal | |
| PE/ATTO 594 | |
| PBS with 0.05% Sodium Azide | |
| EGFR | |
| Human EGFR purified from A431 cells | |
| 0.1 mL | |
| Primary | |
| This MAb recognizes a protein of 170kDa, identified as EGFR. EGFR is type I receptor tyrosine kinase with sequence homology to erbB-1, -2, -3 -4 or HER-1, -2, -3 -4. It binds to Epidermal Growth Factor (EGF), Transforming Growth Factor-a (TGF-a), Heparin-binding EGF (HB-EGF), amphiregulin, Beta cellulin and epiregulin. EGFR is overexpressed in tumors of breast, brain, bladder, lung, gastric, head & neck, esophagus, cervix, vulva, ovary, and endometrium. It is predominantly present in squamous cell carcinomas. | |
| Store at 4°C in the dark. Do not freeze. |
| Flow Cytometry | |
| SPM622 | |
| Flow Cytometry | |
| avian erythroblastic leukemia viral (v-erb-b) oncogene homolog, cell growth inhibiting protein 40, cell proliferation-inducing protein 61, EC 2.7.10, EC 2.7.10.1, epidermal growth factor receptor, epidermal growth factor receptor (avian erythroblastic leukemia viral (v-erb-b)oncogene homolog), ERBB, ErbB1, ERBB1PIG61, HER1, mENA, Proto-oncogene c-ErbB-1, Receptor tyrosine-protein kinase erbB-1 | |
| Mouse | |
| Protein A or G purified | |
| Cancer, Cell Biology, Cell Cycle and Replication, Cellular Markers, Cellular Signaling, Growth and Development, Hypoxia, Phospho Specific, Signal Transduction, Tumor Suppressors, Tyrosine Kinases | |
| 1956.0 | |
| Human | |
| IgG2a κ |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction